Clinical Efficacy of Crizotinib in Treatment of Patients with Advanced NSCLC

Clinical Efficacy of Crizotinib in Treatment of Patients with Advanced NSCLC

Background and objective Crizotinib was developed in recent years based on targets of anaplastic lymphoma kinase (ALK) fusion genes. The aim of this study is to explore the efficacy of crizotinib in treatment of non-small cell lung cancer (NSCLC) with ALK/ROS1 rearrangement. Methods Retrospective an...

Full description

Bibliographic Details
Main Authors: Emei GAO, Jun ZHAO, Minglei ZHUO, Zhijie WANG, Yuyan WANG, Tongtong AN, Meina WU, Xue YANG, Jia ZHONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Anaplastic lymphoma kinase
Crizotinib
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.03.07

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2016.03.07

Similar Items